These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8606350)

  • 1. Transferrin receptors of Neisseria meningitidis: promising candidates for a broadly cross-protective vaccine.
    Ala'Aldeen DA
    J Med Microbiol; 1996 Apr; 44(4):237-43. PubMed ID: 8606350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains.
    Ala'Aldeen DA; Borriello SP
    Vaccine; 1996 Jan; 14(1):49-53. PubMed ID: 8821649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design.
    Ala'Aldeen DA; Stevenson P; Griffiths E; Gorringe AR; Irons LI; Robinson A; Hyde S; Borriello SP
    Infect Immun; 1994 Jul; 62(7):2984-90. PubMed ID: 8005685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservation and antigenic cross-reactivity of the transferrin-binding proteins of Haemophilus influenzae, Actinobacillus pleuropneumoniae and Neisseria meningitidis.
    Holland J; Parsons TR; Hasan AA; Cook SM; Stevenson P; Griffiths E; Williams P
    Microbiology (Reading); 1996 Dec; 142 ( Pt 12)():3505-13. PubMed ID: 9004513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines.
    Lissolo L; Maitre-Wilmotte G; Dumas P; Mignon M; Danve B; Quentin-Millet MJ
    Infect Immun; 1995 Mar; 63(3):884-90. PubMed ID: 7868259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential.
    Gorringe AR; Borrow R; Fox AJ; Robinson A
    Vaccine; 1995 Sep; 13(13):1207-12. PubMed ID: 8578805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo human immune response to transferrin-binding protein 2 and other iron-regulated proteins of Neisseria meningitidis.
    Ferreirós CM; Ferrón L; Criado MT
    FEMS Immunol Med Microbiol; 1994 Jan; 8(1):63-8. PubMed ID: 8156052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains.
    Rokbi B; Mignon M; Maitre-Wilmotte G; Lissolo L; Danve B; Caugant DA; Quentin-Millet MJ
    Infect Immun; 1997 Jan; 65(1):55-63. PubMed ID: 8975892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking of iron uptake from transferrin by antibodies against the transferrin binding proteins in Neisseria meningitidis.
    Pintor M; Ferrón L; Gómez JA; Powell NB; Ala'Aldeen DA; Borriello SP; Criado MT; Ferreirós CM
    Microb Pathog; 1996 Mar; 20(3):127-39. PubMed ID: 8965674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the human Ig isotype response to individual transferrin binding proteins A and B from Neisseria meningitidis.
    Johnson AS; Gorringe AR; Fox AJ; Borrow R; Robinson A
    FEMS Immunol Med Microbiol; 1997 Oct; 19(2):159-67. PubMed ID: 9395061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking of iron uptake by monoclonal antibodies specific for the Neisseria meningitidis transferrin-binding protein 2.
    Pintor M; Ferrón L; Gómez JA; Gorringe A; Criado MT; Ferreirós CM
    J Med Microbiol; 1996 Oct; 45(4):252-7. PubMed ID: 8849698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex.
    Rokbi B; Mignon M; Caugant DA; Quentin-Millet MJ
    Clin Diagn Lab Immunol; 1997 Sep; 4(5):522-9. PubMed ID: 9302199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and antigenic heterogeneity of a human transferrin-binding protein in Neisseria meningitidis.
    Ferron L; Ferreiros CM; Criado MT; Pintor M
    Infect Immun; 1992 Jul; 60(7):2887-92. PubMed ID: 1612755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic relationships of transferrin-binding proteins from Neisseria meningitidis, N. gonorrhoeae and Haemophilus influenzae: cross-reactivity of antibodies to NH2-terminal peptides.
    Griffiths E; Stevenson P; Byfield P; Ala'Aldeen DA; Borriello SP; Holland J; Parsons T; Williams P
    FEMS Microbiol Lett; 1993 May; 109(1):85-91. PubMed ID: 8319886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2.
    Legrain M; Mazarin V; Irwin SW; Bouchon B; Quentin-Millet MJ; Jacobs E; Schryvers AB
    Gene; 1993 Aug; 130(1):73-80. PubMed ID: 8344530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region.
    Kortekaas J; Pettersson A; van der Biezen J; Weynants VE; van der Ley P; Poolman J; Bos MP; Tommassen J
    Vaccine; 2007 Jan; 25(1):72-84. PubMed ID: 16914236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation into the Antigenic Properties and Contributions to Growth in Blood of the Meningococcal Haemoglobin Receptors, HpuAB and HmbR.
    Bidmos FA; Chan H; Praekelt U; Tauseef I; Ali YM; Kaczmarski EB; Feavers I; Bayliss CD
    PLoS One; 2015; 10(7):e0133855. PubMed ID: 26208277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection.
    West D; Reddin K; Matheson M; Heath R; Funnell S; Hudson M; Robinson A; Gorringe A
    Infect Immun; 2001 Mar; 69(3):1561-7. PubMed ID: 11179327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.
    Bai X; Borrow R
    Expert Rev Vaccines; 2010 Oct; 9(10):1203-17. PubMed ID: 20923270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.